Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Weis

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Ebiomedicine|March 26, 2019
Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in SepsisYvonn Heun, Joachim Pircher, Thomas Czermak, et al.
The EMBO Journal|November 17, 2025
Homeostatic control of energy metabolism by monocyte-derived macrophagesRui Martins, Birte Blankehaus, Faouzi Braza, et al.
Plos Pathogens|March 26, 2021
Host cystathionine-γ lyase derived hydrogen sulfide protects against Pseudomonas aeruginosa sepsisGeorgios Renieris, Dionysia-Eirini Droggiti, Konstantina Katrini, et al.
Cell Metabolism|July 16, 2022
A hypometabolic defense strategy against malariaSusana Ramos, Temitope W Ademolue, Elisa Jentho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2021
Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by hemeElisa Jentho, Cristian Ruiz-Moreno, Boris Novakovic, et al.
Clinical & Translational Immunology|March 12, 2021
Lysine methyltransferase G9a is an important modulator of trained immunityVera P Mourits, Jelmer H van Puffelen, Boris Novakovic, et al.
Nature Immunology|January 3, 2024
The pathophysiology of sepsis and precision-medicine-based immunotherapyEvangelos J Giamarellos-Bourboulis, Anna C Aschenbrenner, Michael Bauer, et al.
Cell|April 23, 2025
A type 1 immune-stromal cell network mediates disease tolerance against intestinal infectionSusan Westfall, Maria E Gentile, Tayla M Olsen, et al.
JAMA Network Open|July 2, 2025
Hurdles for the Delivery of Multinational Randomized Clinical TrialsDenise van Hout, Paul Mouncey, David Harrison, et al.
BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Ebiomedicine|March 26, 2019
Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in SepsisYvonn Heun, Joachim Pircher, Thomas Czermak, et al.
The EMBO Journal|November 17, 2025
Homeostatic control of energy metabolism by monocyte-derived macrophagesRui Martins, Birte Blankehaus, Faouzi Braza, et al.
Plos Pathogens|March 26, 2021
Host cystathionine-γ lyase derived hydrogen sulfide protects against Pseudomonas aeruginosa sepsisGeorgios Renieris, Dionysia-Eirini Droggiti, Konstantina Katrini, et al.
Cell Metabolism|July 16, 2022
A hypometabolic defense strategy against malariaSusana Ramos, Temitope W Ademolue, Elisa Jentho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2021
Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by hemeElisa Jentho, Cristian Ruiz-Moreno, Boris Novakovic, et al.
Clinical & Translational Immunology|March 12, 2021
Lysine methyltransferase G9a is an important modulator of trained immunityVera P Mourits, Jelmer H van Puffelen, Boris Novakovic, et al.
Nature Immunology|January 3, 2024
The pathophysiology of sepsis and precision-medicine-based immunotherapyEvangelos J Giamarellos-Bourboulis, Anna C Aschenbrenner, Michael Bauer, et al.
Cell|April 23, 2025
A type 1 immune-stromal cell network mediates disease tolerance against intestinal infectionSusan Westfall, Maria E Gentile, Tayla M Olsen, et al.
JAMA Network Open|July 2, 2025
Hurdles for the Delivery of Multinational Randomized Clinical TrialsDenise van Hout, Paul Mouncey, David Harrison, et al.
BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.
Pageof 11